This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Q2 profit rises; Rs 45 crore expansion and Rs 200 crore debenture redemption approved
NEOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.0 pts less than Nifty Microcap 250 and 6.5 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Q2 FY27 standalone revenue rose 39% to Rs 288 crore and profit after tax rose 127% to Rs 21.14 crore. H1 revenue was Rs 540.28 crore and profit after tax Rs 40.58 crore, but operating cash flow was negative Rs 46.11 crore. The auditor highlighted the Dahej fire insurance claim. The Board approved a Rs 45 crore expansion targeting Rs 150 crore to Rs 200 crore revenue, early redemption of Rs 200 crore debentures and related-party transactions.
Profit growth and expansion are positive; debenture redemption may reduce debt. Cash burn, claim recovery and related-party exposure need monitoring.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹296.0 Cr | ₹208.7 Cr | +41.8% |
| Operating profit | ₹8.76 Cr | ₹3.17 Cr | +176.3% |
| Profit after tax | ₹8.23 Cr | ₹3.37 Cr | +144.2% |
| EBITDA margin | 15.3% | 14.4% | +1.0 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.